Related Experiment Video
Updated: Jun 13, 2026

Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography
Published on: September 22, 2011
beta-Arrestin-dependent activation of Ca(2+)/calmodulin kinase II after beta(1)-adrenergic receptor stimulation
Supachoke Mangmool1, Arun K Shukla, Howard A Rockman
1Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
Abstract:
Ca(2+)/calmodulin kinase II (CaMKII) plays an important role in cardiac contractility and the development of heart failure. Although stimulation of beta(1)-adrenergic receptors (ARs) leads to an increase in CaMKII activity, the molecular mechanism by which beta(1)-ARs activate CaMKII is not completely understood. In this study, we show the requirement for the beta(1)-AR regulatory protein beta-arrestin as a scaffold for both CaMKII and Epac (exchange protein directly activated by cAMP). Stimulation of beta(1)-ARs induces the formation of a beta-arrestin-CaMKII-Epac1 complex, allowing its recruitment to the plasma membrane, whereby interaction with cAMP leads to CaMKII activation. beta-Arrestin binding to the carboxyl-terminal tail of beta(1)-ARs promotes a conformational change within beta-arrestin that allows CaMKII and Epac to remain in a stable complex with the receptor. The essential role for beta-arrestin and identification of the molecular mechanism by which only beta(1)-ARs and not beta(2)-ARs activate CaMKII significantly advances our understanding of this important cellular pathway.
Insights
Beta-arrestin acts as a scaffold protein, forming a complex with CaMKII and Epac to activate CaMKII in response to beta(1)-adrenergic receptor stimulation. This reveals a key mechanism for cardiac contractility regulation and heart failure development.
Area of Science:
- Cardiovascular Biology
- Molecular Pharmacology
- Cell Signaling
Background:
- Calcium/calmodulin-dependent protein kinase II (CaMKII) is crucial for cardiac contractility and heart failure.
- Beta(1)-adrenergic receptor (AR) stimulation increases CaMKII activity, but the activation mechanism remains unclear.
Purpose of the Study:
- To elucidate the molecular mechanism linking beta(1)-AR stimulation to CaMKII activation.
- To identify the role of beta-arrestin in this signaling pathway.
Main Methods:
- Investigated the interaction between beta(1)-AR, beta-arrestin, CaMKII, and Epac.
- Utilized molecular complex formation and recruitment assays.
Main Results:
- Beta-arrestin serves as a scaffold, forming a stable complex with CaMKII and Epac1 upon beta(1)-AR stimulation.
- This complex is recruited to the plasma membrane, leading to cAMP-mediated CaMKII activation.
- Beta-arrestin binding to the beta(1)-AR tail induces conformational changes essential for complex stability.
Conclusions:
- Beta-arrestin is essential for beta(1)-AR-mediated CaMKII activation.
- This study reveals a specific mechanism for beta(1)-ARs, distinguishing them from beta(2)-ARs in CaMKII activation.
- Advances understanding of cardiac signaling pathways relevant to heart failure.
Related Concept Videos
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
GPCRs Regulate Adenylyl Cylase Activity
Two...
Antihypertensive Drugs: Action of Calcium Channel Blockers
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
G-Protein Gated Ion Channels
Sensory organs,...

